Startups assessing tumour therapies with AI modelling, streamlining legislative analysis for public affairs, providing disruptive radio frequency testing, enhancing patient care with digital solutions, and simplifying presentation delivery each win CHF 10,000
25.09.2023
Calico, DemoSquare, EM Path, MedNota, and Showzone win Venture Kick's first stage of financial and entrepreneurial support. Their projects employ digital approaches to assess the potency of therapeutics on patient tumours; develop in-house AI algorithms to report on legislative activities; provide a game-changing solution for wireless system providers; offer an intuitive platform for enhanced patient outcomes and regulatory compliance; and supply a specialized platform for delivering presentations.
 |
 |
 Calico Biosystems CSO Riccardo Turrini and CEO Marie-Agnès Doucey
|
|
 DemoSquare: Victor Kristof and Jérémie Rappaz
|
|
 Showzone: Simon Beyer, Eren Akbiyik, and Nicolas Zanotti
|
|
 EMPath: Mohammad Azadifar
|
|
 MedNota: Ranjit Kalarickamakel and Devon Mahadevan
|
|
Calico Biosystems: Precision Oncology become true for all patients
Both the high attrition rate (> 95%) of therapeutics and the low response rate of patients to approved anti-cancer therapies call for a game changer in therapeutic testing. Calico Biosystems merges innovative experimental and digital approaches to assess the potency of therapeutics on patient tumours. The experimental approach uses the exclusive know-how of the founders in testing therapeutics on native patient tumours, therefore overcoming artificial models. The digital approach, based on computational modelling, predicts the most potent combinations of therapeutics to benefit patients in the clinic. Calico Biosystems' unique service provider platform will be offered to pharma & biotech companies that want to assess the efficacy of their therapeutics in pre-clinical settings, as well as hospitals and clinical trial sponsors, to identify the best combination treatment for each patient in clinics.
The founders, CEO Marie-Agnès Doucey and CSO Riccardo Turrini are former Unil collaborators with more than 15 years of experience in systems immuno-oncology. Calico Biosystems is poised to become the leader of Precision Oncology, by taking 20% in a market estimated to reach 500B USD by 2030.
The Venture Kick grant will be used to further develop the market strategy and increase the visibility among potential customers. calicobiosystems.com
DemoSquare: Democratize democracy
Few aspects impact businesses more than regulation. However, monitoring and reporting on public affairs is a tedious and costly process for companies. DemoSquare aims to save public affairs managers up to 16 hours a week by developing in-house AI algorithms to collect, analyze, and report on legislative activities.
DemoSquare is a SaaS that solves problems for the global 10.8B public affairs market. In Brussels alone, there are 12K interest groups officially registered with the European Parliament, and there are 1 million public affairs managers globally. The EPFL spinoff is founded by two PhDs in artificial intelligence, specializing in the modelling of political processes and information extraction from massive new datasets.
Turning their research into a product, the team is now preparing for their official launch on October 22 with the Swiss Federal elections. A critical mission will be to make parliamentary and public data efficiently and transparently available to citizens while proposing advanced monitoring tools for large organizations.
The Venture Kick funds will provide significant support for product development in Switzerland as well as facilitate the future expansion of DemoSquare into other jurisdictions. demosquare.ch
EM Path: provides a disruptive radio frequency test solution for wireless system providers
Available radio frequency test solutions for wireless systems and antennas typically require large and expensive anechoic chambers. Additionally, they suffer from long test durations due to point-to-point scanning.
EM Path offers a disruptive solution for devices such as phones, automated cars, radars, satellite communication, and IoT devices. This solution can perform the tests in a single shot, eliminating the need for point-to-point scanning. Their new solution is at least 4x more compact, 50x faster, and will enable production line testing. The total market size is estimated to be $1.4 billion in 2023, with a compound annual growth rate of 9.7%.
In close collaboration with the IICT institute HEIG-VD, Dr. Mohammad Azadifar is developing this new test solution to facilitate radio frequency testing. VentureKick funds will be used to develop the calibration and positioning system for the test solution. EM Path
MedNota: Revolutionizing healthcare with innovative digital solutions for enhanced patient care and safety
MedNota is a healthcare technology company specializing in innovative software solutions for hospitals. By providing a robust and intuitive platform, MedNota aims to empower healthcare organizations to proactively identify and address adverse events, enhance patient safety, and streamline regulatory reporting, ultimately leading to improved patient outcomes and regulatory compliance.
MedNota's founders, Ranjit Kalarickamakel and Devon Mahadevan, are seasoned professionals in medical informatics and healthcare technology. With backgrounds in system integration, eHealth, interoperability, and clinical data analytics, they bring valuable expertise to drive MedNota's mission of revolutionizing healthcare through innovative digital solutions.
MedNota will utilize the Venture Kick funds to enhance research and development and expand our digital healthcare solutions, ensuring innovative and impactful products for the healthcare sector. mednota.ch
Showzone: AI-powered presentation delivery platform
Our attention span is very short, and we tend to forget over 80% of the information immediately after a presentation. For presenters, this means their presentation doesn’t pay off: they cannot engage their audience well, and once the presentation ends, they have no way to connect with them.
Showzone addresses these issues by offering a dedicated platform for presentation delivery. Users can simply drag their slides into the Showzone app, where a QR code is generated for audience engagement during the presentation. At the end, a one-click summary of the transcript is created and shared with attendees. Showzone then notifies the presenter about audience interactions with the summary, enabling effective follow-ups with promising leads. The startup targets the communication platform as a service market (CPaaS), which is projected to grow to USD 121 billion in 2032 with a CAGR of 28%.
Showzone team consists of Eren Akbiyik, CEO and AI lead with a patent and research papers, Nicolas Zanotti, CPO with product experience from his long tenure in unicorn start-up GetYourGuide, and Simon Beyer, COO with proven skills in global sales & transformation initiatives as a senior consultant at Ernst&Young.
The Venture Kick funds will allow Showzone to identify the nuances of AI integrations, UI/UX challenges, and user preferences. This will allow them to focus on the business development side, bringing the product to market a lot faster and spurring growth. showzone.app
Both the high attrition rate (> 95%) of therapeutics and the low response rate of patients to approved anti-cancer therapies call for a game changer in therapeutic testing. Calico Biosystems merges innovative experimental and digital approaches to assess the potency of therapeutics on patient tumours. The experimental approach uses the exclusive know-how of the founders in testing therapeutics on native patient tumours, therefore overcoming artificial models. The digital approach, based on computational modelling, predicts the most potent combinations of therapeutics to benefit patients in the clinic. Calico Biosystems' unique service provider platform will be offered to pharma & biotech companies that want to assess the efficacy of their therapeutics in pre-clinical settings, as well as hospitals and clinical trial sponsors, to identify the best combination treatment for each patient in clinics.
The founders, CEO Marie-Agnès Doucey and CSO Riccardo Turrini are former Unil collaborators with more than 15 years of experience in systems immuno-oncology. Calico Biosystems is poised to become the leader of Precision Oncology, by taking 20% in a market estimated to reach 500B USD by 2030.
The Venture Kick grant will be used to further develop the market strategy and increase the visibility among potential customers. calicobiosystems.com
DemoSquare: Democratize democracy
Few aspects impact businesses more than regulation. However, monitoring and reporting on public affairs is a tedious and costly process for companies. DemoSquare aims to save public affairs managers up to 16 hours a week by developing in-house AI algorithms to collect, analyze, and report on legislative activities.
DemoSquare is a SaaS that solves problems for the global 10.8B public affairs market. In Brussels alone, there are 12K interest groups officially registered with the European Parliament, and there are 1 million public affairs managers globally. The EPFL spinoff is founded by two PhDs in artificial intelligence, specializing in the modelling of political processes and information extraction from massive new datasets.
Turning their research into a product, the team is now preparing for their official launch on October 22 with the Swiss Federal elections. A critical mission will be to make parliamentary and public data efficiently and transparently available to citizens while proposing advanced monitoring tools for large organizations.
The Venture Kick funds will provide significant support for product development in Switzerland as well as facilitate the future expansion of DemoSquare into other jurisdictions. demosquare.ch
EM Path: provides a disruptive radio frequency test solution for wireless system providers
Available radio frequency test solutions for wireless systems and antennas typically require large and expensive anechoic chambers. Additionally, they suffer from long test durations due to point-to-point scanning.
EM Path offers a disruptive solution for devices such as phones, automated cars, radars, satellite communication, and IoT devices. This solution can perform the tests in a single shot, eliminating the need for point-to-point scanning. Their new solution is at least 4x more compact, 50x faster, and will enable production line testing. The total market size is estimated to be $1.4 billion in 2023, with a compound annual growth rate of 9.7%.
In close collaboration with the IICT institute HEIG-VD, Dr. Mohammad Azadifar is developing this new test solution to facilitate radio frequency testing. VentureKick funds will be used to develop the calibration and positioning system for the test solution. EM Path
MedNota: Revolutionizing healthcare with innovative digital solutions for enhanced patient care and safety
MedNota is a healthcare technology company specializing in innovative software solutions for hospitals. By providing a robust and intuitive platform, MedNota aims to empower healthcare organizations to proactively identify and address adverse events, enhance patient safety, and streamline regulatory reporting, ultimately leading to improved patient outcomes and regulatory compliance.
MedNota's founders, Ranjit Kalarickamakel and Devon Mahadevan, are seasoned professionals in medical informatics and healthcare technology. With backgrounds in system integration, eHealth, interoperability, and clinical data analytics, they bring valuable expertise to drive MedNota's mission of revolutionizing healthcare through innovative digital solutions.
MedNota will utilize the Venture Kick funds to enhance research and development and expand our digital healthcare solutions, ensuring innovative and impactful products for the healthcare sector. mednota.ch
Showzone: AI-powered presentation delivery platform
Our attention span is very short, and we tend to forget over 80% of the information immediately after a presentation. For presenters, this means their presentation doesn’t pay off: they cannot engage their audience well, and once the presentation ends, they have no way to connect with them.
Showzone addresses these issues by offering a dedicated platform for presentation delivery. Users can simply drag their slides into the Showzone app, where a QR code is generated for audience engagement during the presentation. At the end, a one-click summary of the transcript is created and shared with attendees. Showzone then notifies the presenter about audience interactions with the summary, enabling effective follow-ups with promising leads. The startup targets the communication platform as a service market (CPaaS), which is projected to grow to USD 121 billion in 2032 with a CAGR of 28%.
Showzone team consists of Eren Akbiyik, CEO and AI lead with a patent and research papers, Nicolas Zanotti, CPO with product experience from his long tenure in unicorn start-up GetYourGuide, and Simon Beyer, COO with proven skills in global sales & transformation initiatives as a senior consultant at Ernst&Young.
The Venture Kick funds will allow Showzone to identify the nuances of AI integrations, UI/UX challenges, and user preferences. This will allow them to focus on the business development side, bringing the product to market a lot faster and spurring growth. showzone.app